Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
MS Focus At Sea
MS Focus At Sea offers educational programs, opportunities to meet old and new friends, and adventures for every...
/Events/MSF-Events/MSFocus-Cruise-For-A-Cause
Cooling Program
The Cooling Program offers a variety of items, free of charge, to help individuals with MS...
/Get-Help/MSF-Programs-Grants/Cooling-Program
Shop
Privacy
Terms of Use
Site Map
MS Focus joins effort to preserve copay help for those with chronic diseases
July 28, 2020
MS Focus joined more than 100 organizations to oppose a provision by the Centers for Medicare and Medicaid Services that would increase barriers to access of care and put individuals struggling with chronic and debilitating diseases, such as multiple sclerosis, at risk. They urged the Centers for Medicare and Medicaid Services to omit the provision from the finalized rule.
The provision would require drug manufacturers to include the value of cost-sharing assistance when calculating best price unless they are able to prove that individuals using patient assistance programs, such as copay assistance, are receiving 100 percent of intended benefits. This, the groups argue, would be extremely difficult to prove for manufacturers because of a lack of transparency and the actions of insurers and middlemen.
The groups are concerned the burden of proof will undermine manufacturers’ ability to continue offering patient assistance programs to individuals in the larger commercial market. This is extremely troubling from their perspective, as many patients rely on these programs in order to afford vital drugs and treatments.
To find out more, visit
www.federalregister.gov/documents/2020/06/19/2020-12970/medicaid-program-establishing-minimum-standards-in-medicaid-state-drug-utilization-review-dur-and
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more